GN Store Nord A/S (CPH:GN)
95.12
-0.32 (-0.34%)
Jun 8, 2026, 4:59 PM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 13.9 billion as of June 8, 2026. Its market cap has increased by 0.46% in one year.
Market Cap
13.90B
Enterprise Value
22.99B
Revenue
16.60B
Ranking
n/a
PE Ratio
53.04
Stock Price
95.12
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 13.90B, an increase of 4,109.44%. That is a compound annual growth rate of 11.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 13.90B | -10.59% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 97.22B |
| Coloplast | 86.40B |
| ALK-Abelló | 58.98B |
| H. Lundbeck | 42.96B |
| Zealand Pharma | 22.92B |
| Ambu A/S | 17.48B |
| Bavarian Nordic | 13.97B |